Hyperfine, Inc. has filed a registration statement with the Securities and Exchange Commission (SEC) to offer up to $150 million in various securities. This significant move is aimed at raising capital to support the company’s growth initiatives in the electromedical sector.

The registration statement, filed on November 9, 2026, outlines the potential issuance of Class A common stock, preferred stock, debt securities, and other financial instruments. The filing indicates that Hyperfine intends to utilize a shelf registration process, allowing it to issue these securities over time as market conditions permit.

Background

Hyperfine, Inc. is classified under the Standard Industrial Classification (SIC) code 3845, which pertains to Electromedical & Electrotherapeutic Apparatus. The company is publicly traded on the Nasdaq under the ticker symbol HYPR. Recent filings include a 10-Q and an 8-K, both submitted on the same day as the S-3 filing.

What the Filing Says

The filing specifies that the registration encompasses two main components: a base prospectus and a sales agreement prospectus supplement. The base prospectus allows for the offering of up to $150 million in total securities, while the sales agreement prospectus supplement details a maximum of $50 million in Class A common stock that may be sold through designated sales agents, B. Riley Securities, Inc. and BTIG, LLC.

"This registration statement is being filed to replace the registrant's existing registration statement on Form S-3, which was declared effective on November 22, 2023," the filing states.

Impact

This move may have implications for various stakeholders, including investors, competitors, and the broader electromedical industry. By raising capital, Hyperfine could enhance its research and development efforts, potentially leading to new product innovations and market expansion. Competitors in the electromedical space may also feel the pressure to secure funding for their own advancements and to maintain market share.

What's Next

The filing does not specify what happens next, but it indicates that the company plans to determine the timing and terms of any securities offerings based on market conditions.